Gadoteric acid is a macrocyclic gadolinium-based compound used as a contrast agent in magnetic resonance imaging (MRI). It consists of the organic chelating agent DOTA complexed with gadolinium, typically formulated as the meglumine salt.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72573-82-1
Gadoterate meglumine
pharmaceutical raw material
Gadoteridol
pharmaceutical raw material
Gadobutrol
pharmaceutical raw material
Gadopentetate dimeglumine
pharmaceutical raw material
Gadopiclenol
pharmaceutical raw material
Miglustat
pharmaceutical raw material
Dantrolene
pharmaceutical raw material
(−)-cathinone hydrochloride
pharmaceutical raw material
2-[4,7-bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
GFSTXYOTEVLASN-UHFFFAOYSA-K
C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]